The effect of black tea and caffeine on regional cerebral blood flow measured with arterial spin labeling

Journal of Cerebral Blood Flow and Metabolism

Volumn 33, Issue 6, 2013, Pages 963-968

  Vidyasagar, Rishma ^a   Greyling, Arno ^b   Draijer, Richard ^b   Corfield, Douglas R ^c   Parkes, Laura M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Arterial spin labeling; Brain; Caffeine; Flavonoids; Regional cerebral blood flow; Tea

Indexed keywords

CAFFEINE; FLAVONOID;

ADULT; ARTICLE; BLOOD FLOWMETRY; BLOOD VESSEL REACTIVITY; BRAIN BLOOD FLOW; FOOD INTAKE; GRAY MATTER; HUMAN; HUMAN EXPERIMENT; HYPERCAPNIA; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SPIN LABELING; TEA; THEA NIGRA;

ADULT; BRAIN; CAFFEINE; CAMELLIA SINENSIS; CEREBROVASCULAR CIRCULATION; DOUBLE-BLIND METHOD; HUMANS; HYPERCAPNIA; MAGNETIC RESONANCE IMAGING; MALE; REGIONAL BLOOD FLOW; SPIN LABELS; TEA; YOUNG ADULT;

EID: 84878611588     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2013.40     Document Type: Article

References (40)

1. Arab L, Liu W, Elashoff D. Green and black tea consumption and risk of stroke: a meta-analysis. Stroke 2009; 40: 1786-1792.
2. Feng L, Li J, Ng TP, Lee TS, Kua EH, Zeng Y. Tea drinking and cognitive function in oldest-old chinese. J Nutr Health Aging 2012; 16: 754-758.
3. Ras RT, Streppel MT, Draijer R, Zock PL. Flow-mediated dilation and cardiovascular risk prediction: a systematic review with meta-analysis. Int J Cardiol 2012; S0167-5273: 01153-01159.
4. Kay CD, Hooper L, Kroon PA, Rimm EB, Cassidy A. Relative impact of flavonoid composition, dose and structure on vascular function: a systematic review of randomised controlled trials of flavonoid-rich food products. Mol Nutr Food Res 2012; 56: 1605-1616.
5. Ras RT, Zock PL, Draijer R. Tea consumption enhances endothelial- dependent vasodilation; a meta-analysis. PLoS One 2011; 6: e16974.
6. Grassi D, Desideri G, Ferri C. Blood pressure and cardiovascular risk: What about cocoa and chocolate? Arch Biochem Biophys 2010; 501: 112-115.
7. Lorenz M, Urban J, Engelhardt U, Baumann G, Stangl K, Stangl V. Green and black tea are equally potent stimuli of NO production and vasodilation: new insights into tea ingredients involved. Basic Res Cardiol 2009; 104: 100-110.
8. Groeschel K, Terborg C, Schnaudigel S, Ringer T, Riecker A, Witte OW et al. Effects of physiological aging and cerebrovascular risk factors on the hemodynamic response to brain activation: a functional transcranial Doppler study. Eur J Neurol 2007; 14: 125-131.
9. Hajjar I, Zhao P, Alsop D, Novak V. Hypertension and cerebral vasoreactivity a continuous arterial spin labeling magnetic resonance imaging study. Hypertension 2010; 56: 859-U268.
10. Sorond FA, Lipsitz LA, Hollenberg NK. Fisher NDL. Cerebral blood flow response to flavanol-rich cocoa in healthy elderly humans. Neuropsychiatr Dis Treat 2008; 4: 433-440.
11. Barone JJ, Roberts HR. Caffeine consumption. Food Chem Toxicol 1996; 34: 119-129.
12. Riksen NP, Smits P, Rongen GA. The cardiovascular effects of methylxanthines. Handb Exp Pharmacol 2011; 200: 413-437.
13. Addicott MA, Yang LL, Peiffer AM, Burnett LR, Burdette JH, Chen MY et al. The effect of daily caffeine use on cerebral blood flow: how much caffeine can we tolerate? Hum Brain Mapp 2009; 30: 3102-3114.
14. Biaggioni I, Paul S, Puckett A, Arzubiaga C. Caffeine and theophylline as adeonsine receptor antagonists in humans. J Pharmacol Exp Ther 1991; 258: 588-593.
15. Iliff JJ, D'Ambrosio R, Ngai AC, Winn HR. Adenosine receptors mediate glutamate-evoked arteriolar dilation in the rat cerebral cortex. Am J Physiol -Heart Circ Physiol 2003; 284: H1631-H1637.
16. Williams EJ. Experimental designs balanced for the estimation of residual effects of treatments. Austr J Sci Res Series A Phys Sci 1949; 2: 149-168.
17. Lee MJ, Maliakal P, Chen LS, Meng XF, Bondoc FY, Prabhu S et al. Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3- gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol Biomarkers Prev 2002; 11: 1025-1032.
18. Lelo A, Birkett DJ, Robson RA, Miners JO. Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man. Br J Clin Pharmacol 1986; 22: 177-182.
19. Wong EC, Buxton RB, Frank LR. Quantitative imaging of perfusion using a single subtraction (QUIPSS and QUIPSS II). Magn Reson Med 1998; 39: 702-708.
20. Thesen S, Heid O, Mueller E, Schad LR. Prospective acquisition correction for head motion with image-based tracking for real-time fMRI. Magn Reson Med 2000; 44: 457-463.
21. Mugler JP, Brookeman Jr. 3-Dimensional magnetization-prepared rapid gradientecho imaging (3DMP-RAGE). Magn Reson Med 1990; 15: 152-157.
22. Fenn WO, Craig AB. Effect of CO2 on respiration using a new method of administering CO2. J Appl Physiol 1963; 18: 1023-1024.
23. Parkes LM, Tofts PS. Improved accuracy of human cerebral blood perfusion measurements using arterial spin labeling: accounting for capillary water permeability. Magn Reson Med 2002; 48: 27-41.
24. Roberts DA, Rizi R, Lenkinski RE, Leigh JS. Magnetic resonance imaging of the Brain:Blood partition coefficient for water: application to spin-tagging measurement of perfusion. J Magn Reson Imaging 1996; 6: 363-366.
25. Lu HZ, Clingman C, Golay X, van Zijl PCM. Determining the longitudinal relaxation time (T-1) of blood at 3.0 tesla. Magn Reson Med 2004; 52: 679-682.
26. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002; 15: 273-289.
27. Chen YF, Parrish TB. Caffeine's effects on cerebrovascular reactivity and coupling between cerebral blood flow and oxygen metabolism. Neuroimage 2009; 44: 647-652.
28. Cameron OG, Modell JG, Hariharan M. Caffeine and human cerebral blood flow - a positron emission tomography study. Life Sci 1990; 47: 1141-1146.
29. Ragab S, Lunt M, Birch A, Thomas P, Jenkinson DF. Caffeine reduces cerebral blood flow in patients recovering from an ischaemic stroke. Age Ageing 2004; 33: 299-303.
30. Chen YF, Parrish TB. Caffeine dose effect on activation-induced BOLD and CBF responses. Neuroimage 2009; 46: 577-583.
31. Black KJ, Koller JM, Campbell MC, Gusnard DA, Bandak SI. Quantification of indirect pathway inhibition by the adenosine A(2a) antagonist SYN115 in Parkinson disease. J Neurosci 2010; 30: 16284-16292.
32. Fukumitsu N, Ishii K, Kimura Y, Oda K, Sasaki T, Mori Y et al. Imaging of adenosine A(1) receptors in the human brain by positron emission tomography with [C-11]MPDX. Ann Nucl Med 2003; 17: 511-515.
33. Svenningsson P, Le Moine C, Fisone G, Fredholm BB. Distribution, biochemistry and function of striatal adenosine A(2A) receptors. Prog Neurobiol 1999; 59: 355-396.
34. Ciruela F, Escriche M, Soloviev MM, Canela EI, Burgeno J, Mallol J et al. Adenosineglutamate receptor-receptor interactions in the central nervous system. Drug Dev Res 2001; 52: 316-322.
35. Benowitz NL. Clinical pharmacology of caffeine. Annu Rev Med 1990; 41: 277-288.
36. Rostrup E, Law I, Blinkenberg M, Larsson HBW, Born AP, Holm S et al. Regional differences in the CBF and BOLD responses to hypercapnia: a combined PET and fMRI study. Neuroimage 2000; 11: 87-97.
37. Traystman RJ. Regulation of cerebral blood flow by carbon dioxide. In: Welch KMA (ed). Primer on Cerebrovascular Diseases. Academic Press: CA, USA, 1997, pp 55.
38. Crozier TWM, Stalmach A, Lean MEJ, Crozier A. Espresso coffees, caffeine and chlorogenic acid intake: potential health implications. Food Funct 2012; 3: 30-33.
39. Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R. Association of coffee drinking with total and cause-specific mortality. New EnglJ Med 2012; 366: 1891-1904.
40. Hodgson JM, Puddey IB, Woodman RJ, Mulder TPJ, Fuchs D, Scott K et al. Effects of black tea on blood pressure: a randomized controlled trial. Arch Intern Med 2012; 172: 186-188.